Martin Cranage

5.1k citations

98 papers · 4.3k indexed · h-index 34

Impact in

Virology top 0.1%
- HIV Research and Treatment
Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in

Virology 69
- HIV Research and Treatment 69
Infectious Diseases 32
- HIV/AIDS Research and Interventions 20
- HIV/AIDS drug development and treatment 12

Co-authors: Nicola Cook Erling W. Rud E. J. Stott Michael J. Dennis Neil Almond Geoffrey L. Smith Susanne Bell Sally Sharpe
Journals: Journal of General Virology (8 papers)Journal of Virology (8 papers)Vaccine (5 papers)AIDS (5 papers)Virology (5 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Martin Cranage

97 papers receiving 4.2k citations

Peers

Countries citing papers authored by Martin Cranage

Since Specialization

Citations

This map shows the geographic impact of Martin Cranage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Cranage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Cranage more than expected).

Fields of papers citing papers by Martin Cranage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Cranage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Cranage. The network helps show where Martin Cranage may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin Cranage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Cranage Line = papers co-authored together Martin Cranage links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS PLoS ONE ·Mark Page, Ruby Quartey‐Papafio, Mark W. Robinson, Mark Hassall, Martin Cranage, James Stott, Neil Almond	2014	10
2	Colorectal microbicide design AIDS ·Carolina Herrera, Martin Cranage, Ian McGowan, Peter A. Anton, Robin J. Shattock	2011	37
3	Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses Vaccine ·Rhonda M. Curran, Louise Donnelly, Ryan J. Morrow, Carol Fraser, Gavin P. Andrews, Martin Cranage, Karl Malcolm, Robin J. Shattock, A. David Woolfson	2009	39
4	Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel PLoS Medicine ·Martin Cranage, Sally Sharpe, Carolina Herrera, Alethea Cope, Mike Dennis, Neil Berry, Claire Ham, Jonathan L. Heeney, Naser L. Rezk, Angela D. M. Kashuba, Peter A. Anton, Ian McGowan, Robin J. Shattock	2008	127
5	An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene-gun delivery induces IgG in the lung Vaccine ·Julia A. Tree, G.P. Bembridge, Sam Hou, Geraldine Taylor, Elizabeth Fashola-Stone, Jose ́A. Melero, Martin Cranage	2004	14
6	Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara Virology ·Sally Sharpe, Tomáš Hanke, Anne Tinsley-Bown, Mike Dennis, Stuart Dowall, Andrew J. McMichael, Martin Cranage	2003	33
7	A Conformational C4 Peptide Polymer Vaccine Coupled with Live Recombinant Vector Priming Is Immunogenic But Does Not Protect against Rectal SIV Challenge AIDS Research and Human Retroviruses ·L. Jean Patterson, Frank A. Robey, Andrew Muck, Kier Van Remoortere, Kristine Aldrich, Ersell Richardson, W. Gregory Alvord, Phillip D. Markham, Martin Cranage, Marjorie Robert-Guroff	2001	17
8	Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assays Journal of Immunological Methods ·Sally Sharpe, Brigitte Beer, Graham Hall, Mike Dennis, Stephen Norley, Martin Cranage	2001	3
9	Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection Journal of Medical Primatology ·Peter ten Haaft, Neil Almond, Gunnel Biberfeld, Aurelio Cafaro, Martin Cranage, Barbara Ensoli, Gerhard Hunsmann, Natasha Polyanskaya, Christiane Stahl‐Hennig, Rigmor Thortensson, Fausto Titti, Jonathan L. Heeney	2001	33
10	Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV_macJ5 on the kinetics of SIV replication in cynomolgus monkeys Journal of Medical Primatology ·Donatella Negri, Silvia Baroncelli, Zuleika Michelini, Iole Macchia, Roberto Belli, Stefania Catone, Fabio Incitti, Peter ten Haaft, Franco Corrias, Martin Cranage, Natasha Polyanskaya, Stephen Norley, Jonathan L. Heeney, P. Verani, Fausto Titti	2001	10
11	Mucosal Exposure to Subinfectious Doses of SIV Primes Gut-Associated Antibody-Secreting Cells and T Cells: Lack of Enhancement by Nonneutralizing Antibody Virology ·Natasha Polyanskaya, Lesley A. Bergmeier, Sally Sharpe, Nicola Cook, Sharon Leech, Graham Hall, Mike Dennis, Peter ten Haaft, Jonathan L. Heeney, Fabrizio Manca, Thomas Lehner, Martin Cranage	2001	15
12	Replication of Simian Immunodeficiency Virus (SIV) in ex Vivo Lymph Nodes as a Means to Assess Susceptibility of Macaques in Vivo Virology ·Leonid Margolis, Svetlana Glushakova, Claire Chougnet, G M Shearer, Phil Markham, Marjorie Robert-Guroff, Raoul Ė. Benveniste, Chris Miller, Martin Cranage, Vanessa M. Hirsch, Genoveffa Franchini	2000	5
13	Evidence for the persistence of monoclonal expansions of CD8+ T cells following primary simian immunodeficiency virus infection European Journal of Immunology ·Jamie Wilson, Martin Cranage, Nicola Cook, Sharon Leech, Andrew J. McMichael, Margaret Callan	1998	18
14	Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. Journal of General Virology ·S. Sharpe, Adrian M. Whatmore, Martin Cranage, G.A. Hall	1997	23
15	Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus. PubMed Central ·Lesley A. Bergmeier, John H. Walker, Louisa Tao, Martin Cranage, Thomas Lehner	1994	19
16	Lymphoproliferative Responses in Macaques Immunized with Inactivated SIV Vaccine AIDS Research and Human Retroviruses ·Xin-ce Teng, L.A.E. Ashworth, Sally Sharpe, Michael J. Dennis, Martin Cranage	1993	1
17	Studies on the Specificity of the Vaccine Effect Elicited by Inactivated Simian Immunodeficiency Virus AIDS Research and Human Retroviruses ·Martin Cranage, Natasha Polyanskaya, B.W. McBride, Nicola Cook, L.A.E. Ashworth, Michael J. Dennis, A. Baskerville, P. J. Greenaway, T. Corcoran, P. Kitchin, Jane Rose, Michael Murphey‐Corb, Ronald C. Desrosiers, E. J. Stott, Graham H. Farrar	1993	66
18	Population Sequence Analysis of a Simian Immunodeficiency Virus (32H Reisolate of SIV _mac251 ): A Virus Stock Used for International Vaccine Studies AIDS Research and Human Retroviruses ·Neil Almond, Adrian Jenkins, Andrew Slade, Alan Heath, Martin Cranage, PETE KITCHIN	1992	47
19	Vaccine Studies With the ³² H Reisolate of SIV _mac251 : An Overview AIDS Research and Human Retroviruses ·Martin Cranage, Jim Stott, Kingston H. G. Mills, T. V. ASHWORTH, F. Taffs, Graham H. Farrar, Ling Ling Chan, MIKE DENNIS, Per Putkonen, Gunnel Biberfeld, Michael Murphey‐Corb, Mark Page, A. Baskerville, Peter A. Kitchin, Peter Greenaway	1992	15
20	Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine The Lancet ·E. J. Stott, F. Taffs, P. Kitchin, Woon Ling Chan, Kingston H. G. Mills, Mark Page, Martin Cranage, P. J. Greenaway	1990	142

About Martin Cranage

Martin Cranage is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Microbiology, having authored 98 papers that have together received 4.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (69 papers), Immune Cell Function and Interaction (22 papers), Herpesvirus Infections and Treatments (21 papers), HIV/AIDS Research and Interventions (20 papers), Cytomegalovirus and herpesvirus research (16 papers), Virology and Viral Diseases (13 papers), Virus-based gene therapy research (12 papers) and HIV/AIDS drug development and treatment (12 papers). The work is most often cited by research in Virology (2.7k citations), Immunology (1.7k citations), Infectious Diseases (1.2k citations), Epidemiology (2.2k citations) and Microbiology (194 citations). Martin Cranage has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Nicola Cook, Erling W. Rud, E. J. Stott, Michael J. Dennis, Neil Almond, Geoffrey L. Smith, Susanne Bell, Sally Sharpe, S. Sharpe and G.A. Hall. Their work appears in journals such as Journal of General Virology, Journal of Virology, Vaccine, AIDS and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact